Marvin & Palmer Associates’s CME Group CME Stock Holding History

Marvin & Palmer Associates’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-40,015	Closed	-$8.19M	–	29
2022 Q2	$8.19M	Hold	40,015	–	–	4.21%	13
2022 Q1	$9.52M	Buy	+40,015	New	+$9.4M	4.29%	13
2019 Q1	–	Sell	-40,145	Closed	-$7.55M	–	29
2018 Q4	$7.55M	Sell	40,145 -1,660	-4%	-$307K	6.51%	2
2018 Q3	$7.12M	Buy	41,805 +5,233	+14%	+$881K	5.39%	5
2018 Q2	$6M	Sell	36,572 -3,430	-9%	-$560K	5.9%	3
2018 Q1	$6.47M	Buy	40,002 +6,689	+20%	+$1.06M	5.92%	2
2017 Q4	$4.87M	Buy	33,313 +3,260	+11%	+$464K	5.04%	2
2017 Q3	$4.08M	Sell	30,053 -27,225	-48%	-$3.44M	5.01%	2
2017 Q2	$7.17M	Buy	57,278 +28,745	+101%	+$3.44M	5.44%	1
2017 Q1	$3.39M	Buy	28,533 +14,046	+97%	+$1.69M	2.46%	22
2016 Q4	$1.72M	Sell	14,487 -680	-4%	-$75.7K	1.47%	30
2016 Q3	$1.58M	Buy	+15,167	New	+$1.58M	1.24%	34

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Marvin & Palmer Associates's CME Position: Q3 2022 in Review

Marvin & Palmer Associates sold out of CME Group (CME) in Q3 2022, closing a stake of 40,015 shares — an estimated $8.19M sold.

Marvin & Palmer Associates first reported a position in CME in Q3 2016 and held it in 12 quarters. The position peaked at $9.52M in Q1 2022. 1,146 funds tracked by Wall St. Rank hold CME as of Q3 2022.

Marvin & Palmer Associates reported no remaining CME Group position as of Q3 2022 after selling out during the quarter.
Marvin & Palmer Associates sold 40,015 CME Group shares in Q3 2022, an estimated $8.19M.
Marvin & Palmer Associates first reported a position in CME Group in Q3 2016 and held it in 12 quarters.
Marvin & Palmer Associates's CME Group position peaked at $9.52M in Q1 2022.
1,146 funds tracked by Wall St. Rank held CME Group as of Q3 2022.

Based on Marvin & Palmer Associates's 13F filing for Q3 2022, filed 14 Nov 2022.